Global Point-of-Care Infectious Disease Diagnostics & Testing Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 HIV POC
1.2.3 Clostridium difficile POC
1.2.4 HBV POC
1.2.5 Pneumonia or Streptococcus associated infections
1.2.6 Respiratory syncytial virus (RSV) POC
1.2.7 HPV POC
1.2.8 Influenza/Flu POC
1.2.9 Other Infectious Disease POC
1.3 Market by Application
1.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Perspective (2020-2031)
2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Growth Trends by Region
2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Region (2020-2025)
2.2.3 Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2026-2031)
2.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Dynamics
2.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Trends
2.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
2.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
2.3.4 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue
3.1.1 Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Revenue (2020-2025)
3.1.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Players (2020-2025)
3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point-of-Care Infectious Disease Diagnostics & Testing Revenue
3.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio
3.4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2024
3.5 Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing Head office and Area Served
3.6 Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing, Product and Application
3.7 Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Type (2020-2025)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2026-2031)
5 Point-of-Care Infectious Disease Diagnostics & Testing Breakdown Data by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Historic Market Size by Application (2020-2025)
5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2020-2031)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025)
6.4 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2020-2031)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025)
7.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2020-2031)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2020-2031)
9.2 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025)
9.4 Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size (2020-2031)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.1.4 Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.3.4 Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.4.4 Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.4.5 Siemens Healthineers Recent Development
11.5 BD & Company
11.5.1 BD & Company Company Details
11.5.2 BD & Company Business Overview
11.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.5.4 BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.5.5 BD & Company Recent Development
11.6 Chembio Diagnostics Inc.
11.6.1 Chembio Diagnostics Inc. Company Details
11.6.2 Chembio Diagnostics Inc. Business Overview
11.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.6.4 Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.6.5 Chembio Diagnostics Inc. Recent Development
11.7 Trinity Biotech
11.7.1 Trinity Biotech Company Details
11.7.2 Trinity Biotech Business Overview
11.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.7.4 Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.7.5 Trinity Biotech Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Details
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.8.4 Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.8.5 Cardinal Health Recent Development
11.9 Quest Diagnostics Inc.
11.9.1 Quest Diagnostics Inc. Company Details
11.9.2 Quest Diagnostics Inc. Business Overview
11.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.9.4 Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.9.5 Quest Diagnostics Inc. Recent Development
11.10 Bio-Rad Labs Inc.
11.10.1 Bio-Rad Labs Inc. Company Details
11.10.2 Bio-Rad Labs Inc. Business Overview
11.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.10.4 Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.10.5 Bio-Rad Labs Inc. Recent Development
11.11 bioMérieux SA
11.11.1 bioMérieux SA Company Details
11.11.2 bioMérieux SA Business Overview
11.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.11.4 bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.11.5 bioMérieux SA Recent Development
11.12 Sight Diagnostics Ltd.
11.12.1 Sight Diagnostics Ltd. Company Details
11.12.2 Sight Diagnostics Ltd. Business Overview
11.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.12.4 Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.12.5 Sight Diagnostics Ltd. Recent Development
11.13 Gene POC
11.13.1 Gene POC Company Details
11.13.2 Gene POC Business Overview
11.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.13.4 Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.13.5 Gene POC Recent Development
11.14 Trivitron Healthcare
11.14.1 Trivitron Healthcare Company Details
11.14.2 Trivitron Healthcare Business Overview
11.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.14.4 Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.14.5 Trivitron Healthcare Recent Development
11.15 OJ-Bio Ltd.
11.15.1 OJ-Bio Ltd. Company Details
11.15.2 OJ-Bio Ltd. Business Overview
11.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.15.4 OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.15.5 OJ-Bio Ltd. Recent Development
11.16 Ortho-Clinical Diagnostics
11.16.1 Ortho-Clinical Diagnostics Company Details
11.16.2 Ortho-Clinical Diagnostics Business Overview
11.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Introduction
11.16.4 Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
11.16.5 Ortho-Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of HIV POC
Table 3. Key Players of Clostridium difficile POC
Table 4. Key Players of HBV POC
Table 5. Key Players of Pneumonia or Streptococcus associated infections
Table 6. Key Players of Respiratory syncytial virus (RSV) POC
Table 7. Key Players of HPV POC
Table 8. Key Players of Influenza/Flu POC
Table 9. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2020-2025)
Table 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2026-2031)
Table 15. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
Table 16. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
Table 17. Point-of-Care Infectious Disease Diagnostics & Testing Market Challenges
Table 18. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
Table 19. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Players (2020-2025)
Table 21. Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2024)
Table 22. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics & Testing Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing, Headquarters and Area Served
Table 25. Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing, Product and Application
Table 26. Global Key Players of Point-of-Care Infectious Disease Diagnostics & Testing, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2020-2025)
Table 30. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type (2026-2031)
Table 32. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application (2020-2025)
Table 34. Global Point-of-Care Infectious Disease Diagnostics & Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application (2026-2031)
Table 36. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 54. Abbott Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Thermo Fisher Scientific Inc Company Details
Table 57. Thermo Fisher Scientific Inc Business Overview
Table 58. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 59. Thermo Fisher Scientific Inc Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Scientific Inc Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 64. Roche Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 69. Siemens Healthineers Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 70. Siemens Healthineers Recent Development
Table 71. BD & Company Company Details
Table 72. BD & Company Business Overview
Table 73. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 74. BD & Company Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 75. BD & Company Recent Development
Table 76. Chembio Diagnostics Inc. Company Details
Table 77. Chembio Diagnostics Inc. Business Overview
Table 78. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 79. Chembio Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 80. Chembio Diagnostics Inc. Recent Development
Table 81. Trinity Biotech Company Details
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 84. Trinity Biotech Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. Cardinal Health Company Details
Table 87. Cardinal Health Business Overview
Table 88. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 89. Cardinal Health Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 90. Cardinal Health Recent Development
Table 91. Quest Diagnostics Inc. Company Details
Table 92. Quest Diagnostics Inc. Business Overview
Table 93. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 94. Quest Diagnostics Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 95. Quest Diagnostics Inc. Recent Development
Table 96. Bio-Rad Labs Inc. Company Details
Table 97. Bio-Rad Labs Inc. Business Overview
Table 98. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 99. Bio-Rad Labs Inc. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 100. Bio-Rad Labs Inc. Recent Development
Table 101. bioMérieux SA Company Details
Table 102. bioMérieux SA Business Overview
Table 103. bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 104. bioMérieux SA Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 105. bioMérieux SA Recent Development
Table 106. Sight Diagnostics Ltd. Company Details
Table 107. Sight Diagnostics Ltd. Business Overview
Table 108. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 109. Sight Diagnostics Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 110. Sight Diagnostics Ltd. Recent Development
Table 111. Gene POC Company Details
Table 112. Gene POC Business Overview
Table 113. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 114. Gene POC Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 115. Gene POC Recent Development
Table 116. Trivitron Healthcare Company Details
Table 117. Trivitron Healthcare Business Overview
Table 118. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 119. Trivitron Healthcare Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 120. Trivitron Healthcare Recent Development
Table 121. OJ-Bio Ltd. Company Details
Table 122. OJ-Bio Ltd. Business Overview
Table 123. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 124. OJ-Bio Ltd. Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 125. OJ-Bio Ltd. Recent Development
Table 126. Ortho-Clinical Diagnostics Company Details
Table 127. Ortho-Clinical Diagnostics Business Overview
Table 128. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product
Table 129. Ortho-Clinical Diagnostics Revenue in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025) & (US$ Million)
Table 130. Ortho-Clinical Diagnostics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report


List of Figures
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Type: 2024 VS 2031
Figure 4. HIV POC Features
Figure 5. Clostridium difficile POC Features
Figure 6. HBV POC Features
Figure 7. Pneumonia or Streptococcus associated infections Features
Figure 8. Respiratory syncytial virus (RSV) POC Features
Figure 9. HPV POC Features
Figure 10. Influenza/Flu POC Features
Figure 11. Other Infectious Disease POC Features
Figure 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Application: 2024 VS 2031
Figure 14. Hospitals Case Studies
Figure 15. Clinics Case Studies
Figure 16. Home Case Studies
Figure 17. Assisted Living Healthcare Facilities Case Studies
Figure 18. Laboratories Case Studies
Figure 19. Others Case Studies
Figure 20. Point-of-Care Infectious Disease Diagnostics & Testing Report Years Considered
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region: 2024 VS 2031
Figure 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Players in 2024
Figure 25. Global Top Point-of-Care Infectious Disease Diagnostics & Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-Care Infectious Disease Diagnostics & Testing as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2024
Figure 27. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2020-2031)
Figure 29. United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2020-2031)
Figure 33. Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Region (2020-2031)
Figure 41. China Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2020-2031)
Figure 49. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Country (2020-2031)
Figure 53. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Point-of-Care Infectious Disease Diagnostics & Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 57. Thermo Fisher Scientific Inc Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 59. Siemens Healthineers Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 60. BD & Company Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 61. Chembio Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 62. Trinity Biotech Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 63. Cardinal Health Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 64. Quest Diagnostics Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 65. Bio-Rad Labs Inc. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 66. bioMérieux SA Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 67. Sight Diagnostics Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 68. Gene POC Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 69. Trivitron Healthcare Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 70. OJ-Bio Ltd. Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 71. Ortho-Clinical Diagnostics Revenue Growth Rate in Point-of-Care Infectious Disease Diagnostics & Testing Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit